W
CC icon

Wealthfront’s Chemours CC Stock Holding History

Wealthfront’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,145
Closed -$202K – 505
2018
Q1 		$202K Buy
4,145
+56
+1% +$2.8K ﹤0.01% 499
2017
Q4 		$205K Sell
4,089
-21
-0.5% -$1.1K ﹤0.01% 491
2017
Q3 		$208K Buy
+4,110
New +$194K ﹤0.01% 490
2015
Q4 		– Sell
-195
Closed -$1K – 402
2015
Q3 		$1K Buy
+195
New +$2.04K ﹤0.01% 1197

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealthfront's CC Position: Q2 2018 in Review

Wealthfront sold out of Chemours (CC) in Q2 2018, closing a stake of 4,145 shares — an estimated $202K sold.

Wealthfront first reported a position in CC in Q3 2015 and held it in 4 quarters. The position peaked at $208K in Q3 2017. 559 funds tracked by Wall St. Rank hold CC as of Q2 2018.

  • Wealthfront reported no remaining Chemours position as of Q2 2018 after selling out during the quarter.
  • Wealthfront sold 4,145 Chemours shares in Q2 2018, an estimated $202K.
  • Wealthfront first reported a position in Chemours in Q3 2015 and held it in 4 quarters.
  • Wealthfront's Chemours position peaked at $208K in Q3 2017.
  • 559 funds tracked by Wall St. Rank held Chemours as of Q2 2018.

Based on Wealthfront's 13F filing for Q2 2018, filed 10 Aug 2018.